1. Gilead says remdesivir cut risk of COVID patient death in clinical trial — BioNTech-Pfizer COVID vaccine expected to be ready for approval by year end — LEO Pharma eyeing 2021 launch for Dupixent rival — See more on our front page news Stay updated with the latest pharma-related coronavirus news on our new page
    Dismiss Notice
  2. Please take our quick survey on how COVID-19 is impacting your job It will only take a minute or two to respond. The survey is confidential, and does not require registration. Thank you in advance for your participation. We will provide regular updates on results as responses accumulate.
    Dismiss Notice

What can we get IT to say?

Discussion in 'Allergan' started by anonymous, Feb 7, 2020 at 4:22 PM.

Tags: Add Tags
  1. anonymous

    anonymous Guest

    Cast a line and see what bites. Let me say this, I'd rather work a job cleaning up nastiness and working terrible hours for $12.65/hour rather than go back into pharmaceutical sales. How about that?
     

  2. anonymous

    anonymous Guest

    what do you want to know?
     
  3. anonymous

    anonymous Guest

    What's up with Liletta?